| Business Summary | | MGI
Pharma,
Inc.
is
an
oncology-focused
pharmaceutical
company
that
acquires,
develops
and
commercializes
proprietary
pharmaceutical
products
that
meet
patient
needs.
The
Company
markets
four
cancer-related
products
in
the
United
States.
Salagen
Tablets
treats
symptoms
of
radiation-induced
xerostomia,
known
as
chronic
dry
mouth,
in
head
and
neck
cancer
patients,
and
to
rheumatologists
as
a
treatment
for
the
xerostomia
associated
with
the
autoimmune
disease
Sjogren's
syndrome.
The
Company
also
sells
Didronel
I.V.
Infusion,
which
is
approved
for
the
treatment
of
elevated
blood
calcium
in
late-stage
cancer
patients.
The
Company
distributes
Hexalen
Capsules,
a
second-line
chemotherapy
for
ovarian
cancer
patients
who
are
refractory,
or
unresponsive,
to
existing
cancer
therapies.
MGI
also
began
direct
promotion
of
Hexalen
Capsules
and
Mylocel
Tablets,
a
treatment
for
certain
malignancies. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | MOGN
is
a
human
pharmaceutical
company
that
acquires,
develops
and
markets
differentiated,
specialty
pharmaceutical
products.
MOGN
currently
promotes
products
with
uses
in
oncology
and
rheumatology.
For
the
six
months
ended
6/30/01,
total
revenues
rose
49%
to
$18.6
million.
Net
loss
before
acct.
change
totalled
$18.5
million,
vs.
an
income
of
$408
thousand.
Results
reflect
increased
demand
and
prices
for
Salagen
Tablets,
offset
by
sales
force
expansion
and
higher
R
and
D
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Charles Blitzer, 60 Pres,
CEO, Director | $580K | $330K | William Brown, 45 CFO,
Sec. | 257K | 66K | Leon Moulder, Jr., 43 Exec.
VP | 300K | -- | John MacDonald, 47 Sr.
VP, R&D | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|